Establishing innovative approaches for optimal infection prevention of resistant bacteria in NICUs by integrating research, implementation science and surveillance in a sustainable global platform.
Julia Bielicki is the CI
Funder
Horizon 2020 research and innovation programme under grant agreement No 965328
Sponsor
Penta
Type of Study
Observational
Sites
UK, Germany, Switzerland, Estonia, Greece, Italy, Spain, Slovenia, Poland, South Africa
Patients
Neonates in NICUs at time of survey
Summary
This colonisation assessment aims to study the feasibility of assessing resistant bacterial colonisation pressure and modelling infant colonisation dynamics by using anonymous data and samples from repeated cross-sectional assessments collecting non-invasive samples (e.g. skin swabs and stool) that would typically be used as part of surveillance and quality management in NICUs. These samples will be subjected to pooled genomic analyses using genetic (artificial) tags corresponding to anonymised participant ID numbers to establish colonisation pressure for clinically important resistant bacteria in a range of European neonatal intensive care units (NICUs).
Duration
April 2021 – March 2026
